
Research Guide
Every compound in our catalog, with the effects and limitations reported in publicly available preclinical and clinical literature. Use it to narrow down which compound fits a given study design.
Nothing here is medical advice, and none of these compounds are approved for human use. All items are supplied strictly for laboratory research.
06 Compounds
Incretin agonists, lipolytic agents and metabolic modulators. The most heavily studied area of the catalog.
Triple GLP-1 / GIP / Glucagon agonist
A triple receptor agonist that engages GLP-1, GIP and glucagon simultaneously. Of the incretin-class molecules in circulation it is associated with the largest reported reductions in fat mass, alongside measurable shifts in glycemic markers and hepatic lipid content.
Reported benefits
Reported drawbacks
Available: GLP-RT10 10mg · GLP-RT15 15mg · GLP-RT20 20mg · GLP-RT30 30mg · GLP-RT60 60mg
Dual GLP-1 / GIP agonist
A dual agonist of the GLP-1 and GIP receptors. Research describes dose-dependent insulin secretion, suppressed glucagon output, delayed gastric emptying and pronounced appetite reduction, with fat-mass loss that scales with the titration schedule.
Reported benefits
Reported drawbacks
Available: GLP-TR10 10mg · GLP-TR15 15mg · GLP-TR20 20mg · GLP-TR30 30mg · GLP-TR40 40mg · GLP-TR50 50mg · GLP-TR60 60mg
Small-molecule NNMT inhibitor
A small molecule that inhibits nicotinamide N-methyltransferase, an enzyme found at elevated levels in adipose tissue. Inhibition raises cellular NAD+ and SAM availability and is linked to reduced fat mass in animal models without appetite suppression.
Reported benefits
Reported drawbacks
Available: 5-Amino-1MQ 10mg · 5-Amino-1MQ 50mg
ERR agonist, exercise-mimetic research compound
An agonist of the estrogen-related receptors that upregulates the oxidative machinery normally triggered by training. Animal work reports gains in endurance capacity and fat oxidation without an increase in activity volume.
Reported benefits
Reported drawbacks
Available: SLU-PP-332 5mg
Lipolytic solution for localized fat research
A multi-component lipolytic solution studied for site-specific fat reduction. Research focuses on localized adipocyte breakdown rather than systemic metabolic change.
Reported benefits
Reported drawbacks
Available: Lemon Bottle 10ml
Metabolic signalling compound
An early-stage metabolic signalling compound studied for cellular energy regulation, lipid metabolism and receptor-level modulation of energy homeostasis. Its mechanism differs from the incretin agonists, which makes it useful as a comparison arm in metabolic study designs.
Reported benefits
Reported drawbacks
Available: MS10 10mg
04 Compounds
Neuropeptides studied for cognition, stress response and sleep architecture.
Synthetic ACTH(4-10) analog
A heptapeptide derived from ACTH that modulates BDNF expression and dopaminergic and serotonergic signalling. Most commonly researched for attention, learning and neuroprotection.
Reported benefits
Reported drawbacks
Available: Semax 10mg
Tuftsin-derived anxiolytic heptapeptide
A synthetic analog of the immunopeptide tuftsin, studied for anxiety reduction without sedation or dependence. Research points to GABA and serotonin modulation plus cytokine regulation.
Reported benefits
Reported drawbacks
Available: Selank 10mg
Delta sleep inducing peptide
A nonapeptide originally isolated from cerebral venous blood during induced sleep. Studied for sleep onset, restoration of circadian rhythm and stress-axis modulation.
Reported benefits
Reported drawbacks
Available: DSIP 10mg
Targeted synaptic modulator
A cognitive research peptide investigated for its influence on synaptic function, neuroplasticity and neuronal signalling. It sits in the emerging nootropic class, studied for neuroprotective pathways and cognitive performance in preclinical models.
Reported benefits
Reported drawbacks
Available: TSM 10mg
03 Compounds
Growth-hormone secretagogues and GHRH analogs used to study the somatotropic axis.
GHRH(1-44) analog
A stabilized analog of growth-hormone-releasing hormone. Research centres on visceral adipose tissue reduction and IGF-1 elevation through endogenous GH release rather than exogenous GH administration.
Reported benefits
Reported drawbacks
Available: Tesamorelin 10mg · Tesamorelin 20mg
GHRH analog with selective GH secretagogue
A pairing of a modified GHRH analog with a selective ghrelin-receptor secretagogue. The two act on different pathways, producing a larger and more physiological GH pulse than either alone.
Reported benefits
Reported drawbacks
Available: CJC1295 + Ipamorelin 10mg
Melanocortin receptor agonist
A cyclic analogue of alpha-MSH studied for central melanocortin signalling rather than vascular effects. Research interest sits in hypothalamic MC4R activity and the desire pathways downstream of it.
Reported benefits
Reported drawbacks
Available: PT-141 10mg
04 Compounds
Mitochondrial, telomere and cellular-energy research compounds.
Nicotinamide adenine dinucleotide
A coenzyme central to redox metabolism, mitochondrial ATP production and sirtuin signalling. Endogenous levels decline with age, which is the basis for most longevity research using it.
Reported benefits
Reported drawbacks
Available: NAD+ 500mg · NAD+ 1000mg
Mitochondrial-derived metabolic peptide
A 16-amino-acid peptide encoded in the mitochondrial genome. It regulates metabolic homeostasis and insulin sensitivity through AMPK activation and is studied for exercise capacity.
Reported benefits
Reported drawbacks
Available: MOTS-c 10mg · MOTS-c 20mg · MOTS-c 40mg
Mitochondria-targeted tetrapeptide
An elamipretide-class tetrapeptide that concentrates inside the inner mitochondrial membrane and stabilizes cardiolipin. Studied mainly in models of mitochondrial dysfunction and ischemia-reperfusion.
Reported benefits
Reported drawbacks
Available: SS-31 10mg
Telomerase-associated tetrapeptide
A synthetic tetrapeptide modeled on epithalamin from the pineal gland. Research focuses on telomerase activation, melatonin rhythm and markers of cellular aging.
Reported benefits
Reported drawbacks
Available: Epithalon 10mg
06 Compounds
Repair-focused compounds studied for connective tissue, angiogenesis and inflammation control.
Body protection compound
A pentadecapeptide derived from gastric juice protein. It is one of the most researched repair peptides, with models covering tendon, muscle, gut lining and gastric ulcer healing.
Reported benefits
Reported drawbacks
Available: BPC-157 10mg
Thymosin beta-4 fragment
A synthetic fragment of thymosin beta-4 that promotes actin regulation and cell migration. Studied for flexibility, wound closure and recovery from strain injuries.
Reported benefits
Reported drawbacks
Available: TB-500 10mg
BPC-157 with TB-500
A pre-mixed pairing of the two best-known repair peptides. The combination is studied for the complementary pathways it covers: local tissue repair alongside systemic cell migration and remodelling.
Reported benefits
Reported drawbacks
Available: Wolverine Stack 20mg
Long-arginine insulin-like growth factor 1
An extended-half-life analog of IGF-1 with reduced binding-protein affinity. Studied for muscle protein synthesis, nutrient partitioning and cellular growth signalling.
Reported benefits
Reported drawbacks
Available: IGF-1LR3 1mg
Anti-inflammatory tripeptide
A tripeptide fragment of alpha-MSH with concentrated anti-inflammatory activity. Researched primarily in gut inflammation, skin conditions and immune signalling.
Reported benefits
Reported drawbacks
Available: KPV 10mg
Non-erythropoietic EPO-derived peptide
A short peptide derived from erythropoietin that retains its tissue-protective signalling without stimulating red blood cell production. Studied for neuropathy and inflammation-driven damage.
Reported benefits
Reported drawbacks
Available: ARA-290 10mg
04 Compounds
Compounds studied for skin architecture, pigmentation, oxidative load and cellular aesthetics.
Copper tripeptide-1
A copper-binding tripeptide found naturally in human plasma, where levels fall with age. Research covers collagen synthesis, elastin production, wound remodelling and hair follicle signalling.
Reported benefits
Reported drawbacks
Available: GHK-Cu 50mg · GHK-Cu 100mg
Master intracellular antioxidant
The body’s principal endogenous antioxidant, central to detoxification, redox balance and melanin regulation. Studied for oxidative load reduction and skin clarity.
Reported benefits
Reported drawbacks
Available: Glutathione 1500mg
GHK-Cu, BPC-157 and TB-500 blend
A cosmetic-focused blend pairing the copper peptide with two repair peptides. Designed to combine collagen support with faster tissue remodelling for skin-focused research.
Reported benefits
Reported drawbacks
Available: Glow 70mg
Multi-peptide aesthetic blend
A four-component blend formulated for skin quality and localized fat research. Each vial carries four independently assayed peptides, all verified in the corresponding certificate of analysis.
Reported benefits
Reported drawbacks
Available: Klow 80mg
Research Use Only
The information on this page summarizes published research and is provided for educational purposes only. It is not a claim of efficacy, safety or intended use for any product sold by Enhanced Aminos. All compounds are sold strictly for in vitro laboratory research and are not for human or veterinary consumption.